Pages that link to "Q34057451"
Jump to navigation
Jump to search
The following pages link to Relationship of octanol/water partition coefficient and molecular weight to rat brain capillary permeability (Q34057451):
Displaying 50 items.
- Identification of novel functional inhibitors of acid sphingomyelinase (Q21003953) (← links)
- Brain uptake, retention, and efflux of aluminum and manganese (Q24812347) (← links)
- The Role of Cell-Penetrating Peptide and Transferrin on Enhanced Delivery of Drug to Brain (Q26745586) (← links)
- Multifunctional nanoparticles for brain tumor imaging and therapy (Q26865418) (← links)
- Preclinical pharmacokinetic and pharmacodynamic evaluation of novel anticancer agents, ON01910.Na (Rigosertib, Estybon™) and ON013105, for brain tumor chemotherapy (Q28268434) (← links)
- Functional clarification of MCT1-mediated transport of monocarboxylic acids at the blood-brain barrier using in vitro cultured cells and in vivo BUI studies (Q28373047) (← links)
- Evaluation of blood-brain barrier passage of a muscarine M1 agonist and a series of analogous tetrahydropyridines measured by in vivo microdialysis (Q28373051) (← links)
- Nanoparticles for imaging and treating brain cancer (Q28394053) (← links)
- Functional characterisation of the maturation of the blood-brain barrier in larval zebrafish (Q28534449) (← links)
- Blinded predictions of distribution coefficients in the SAMPL5 challenge (Q28818251) (← links)
- Permeability imaging in pediatric brain tumors (Q30392559) (← links)
- Targeted drug delivery across the blood-brain barrier using ultrasound technique (Q30474781) (← links)
- Gd(3+) complexes conjugated to Pittsburgh compound B: potential MRI markers of β-amyloid plaques. (Q30706028) (← links)
- Strategies to overcome the barrier: use of nanoparticles as carriers and modulators of barrier properties (Q30768284) (← links)
- Computation of log BB values for compounds transported through carrier-mediated mechanisms using in vitro permeability data from brain microvessel endothelial cell (BMEC) monolayers. (Q30782686) (← links)
- Separation methods that are capable of revealing blood-brain barrier permeability (Q30884499) (← links)
- Amyloid imaging: from benchtop to bedside (Q31024441) (← links)
- Recent advances in blood-brain barrier disruption as a CNS delivery strategy (Q31154008) (← links)
- Characterization of (111)In(3+) complexes of DTPA amide derivatives: biodistribution and clearance studied by gamma imaging. (Q31514731) (← links)
- Considerations in the use of cerebrospinal fluid pharmacokinetics to predict brain target concentrations in the clinical setting: implications of the barriers between blood and brain. (Q32181067) (← links)
- Lysosomal trapping as an important mechanism involved in the cellular distribution of perazine and in pharmacokinetic interaction with antidepressants (Q33179423) (← links)
- Quantitative visualization of passive transport across bilayer lipid membranes (Q33369001) (← links)
- Fotemustine as second-line treatment for recurrent or progressive glioblastoma after concomitant and/or adjuvant temozolomide: a phase II trial of Gruppo Italiano Cooperativo di Neuro-Oncologia (GICNO). (Q33382912) (← links)
- Treatment of recurrent malignant gliomas with fotemustine monotherapy: impact of dose and correlation with MGMT promoter methylation (Q33383951) (← links)
- A new schedule of fotemustine in temozolomide-pretreated patients with relapsing glioblastoma. (Q33391296) (← links)
- Characteristics of compounds that cross the blood-brain barrier (Q33469828) (← links)
- Barrier mechanisms in the brain, I. Adult brain. (Q33535015) (← links)
- Use of immobilized artificial membrane chromatography for drug transport applications (Q33585693) (← links)
- Nanoparticle-mediated brain-specific drug delivery, imaging, and diagnosis (Q33622573) (← links)
- Localized paclitaxel delivery (Q33653428) (← links)
- Biomaterials for Local, Controlled Drug Delivery to the Injured Spinal Cord. (Q33653678) (← links)
- Targeting protein kinases in central nervous system disorders (Q33671660) (← links)
- The distribution of aluminum into and out of the brain. (Q33804368) (← links)
- Determinants of passive drug entry into the central nervous system (Q33851314) (← links)
- P-Glycoprotein, a gatekeeper in the blood-brain barrier (Q33904245) (← links)
- Recent advances in the brain targeting of neuropharmaceuticals by chemical delivery systems (Q33904251) (← links)
- Selective boron drug delivery to brain tumors for boron neutron capture therapy (Q33933118) (← links)
- Medicinal chemical properties of successful central nervous system drugs (Q33946968) (← links)
- Vector-mediated drug delivery to the brain (Q33956192) (← links)
- Drug delivery to brain via the blood-brain barrier (Q33963752) (← links)
- How to measure drug transport across the blood-brain barrier (Q33985116) (← links)
- Targeting drugs to the brain by redox chemical delivery systems. (Q33996838) (← links)
- Expression and function of multidrug resistance transporters at the blood-brain barriers (Q33998841) (← links)
- Advances in strategies to improve drug delivery to brain tumors (Q34000631) (← links)
- A method to predict blood-brain barrier permeability of drug-like compounds using molecular dynamics simulations (Q34031018) (← links)
- Comparison of lipid-mediated blood-brain-barrier penetrability in neonates and adults (Q34056959) (← links)
- The use of intracerebral microdialysis to determine changes in blood-brain barrier transport characteristics. (Q34058742) (← links)
- Complete in vivo reversal of P-glycoprotein pump function in the blood-brain barrier visualized with positron emission tomography (Q34067336) (← links)
- BBB transport and P-glycoprotein functionality using MDR1A (-/-) and wild-type mice. Total brain versus microdialysis concentration profiles of rhodamine-123. (Q34067977) (← links)
- Methodological issues in microdialysis sampling for pharmacokinetic studies (Q34100148) (← links)